UNIFOB STIFTELSEN UNIVERSITETS has a total of 21 patent applications. Its first patent ever was published in 1995. It filed its patents most often in Norway, EPO (European Patent Office) and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are IDAC THERANOSTICS INC, TECHNOLOGY LICENCE CO LTD and PALLEON PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Norway | 8 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Australia | 3 | |
#4 | Canada | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Finland | 1 | |
#7 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Chemical engineering | |
#5 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Lien Torleiv | 9 |
#2 | Lillehaug Johan R | 9 |
#3 | Jonassen Inge | 9 |
#4 | Jensen Harald B | 9 |
#5 | Eidhammer Ingvar | 9 |
#6 | Lossius Ivar | 9 |
#7 | Birkeland Nils Kaare | 6 |
#8 | Zorzato Francesco | 5 |
#9 | Helland Dag E | 5 |
#10 | Skeie Geir Olve | 5 |
Publication | Filing date | Title |
---|---|---|
AU2005201137A1 | Detection of Ryanodine Receptor Antibodies | |
AU2002241409A1 | Metylococcus capsulatus genes and dna array for the determination of gene expression in metylococcus capsulatus | |
WO02055549A2 | Systems for expression of heterologous proteins in m. capsulatus | |
EP1029246A1 | A method and device for preventing immunoglobulin degradation in external secretions | |
CA2202467A1 | Use of anthocyanidin and derivatives for treatment of retroviral infections |